Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03403426 · ClinicalTrials.gov registry record · NA
ReFlow Medical Wingman Catheter Wing-IT Clinical Trial
A NA study, sponsored by ReFlow Medical.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT03403426: Completed NA study, sponsored by ReFlow Medical.
NCT03403426 is a NA study that has completed, run by ReFlow Medical. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03403426, a NA study, has completed, sponsored by ReFlow Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the ReFlow Medical Wingman Catheter used to cross de novo or restenotic infrainguinal CTOs that cannot be crossed with a standard guidewire.
Primary Outcome
While using the Wingman device, successful CTO crossing is identified by successful guidewire placement in the distal true lumen confirmed by angiography with no clinically significant perforations. Assessment by angiography with results reviewed by an independent core lab.
Interventions
- DEVICE Wingman Crossing Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2018-02-13 |
| Est. Completion | 2019-08-08 |
| Phase | NA |
What the finished NCT03403426 record still lists
NCT03403426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Wingman Crossing Catheter is the first listed.
NCT03403426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03403426 about?
NCT03403426 is a clinical study titled "ReFlow Medical Wingman Catheter Wing-IT Clinical Trial". To evaluate the safety and effectiveness of the ReFlow Medical Wingman Catheter used to cross de novo or restenotic infrainguinal CTOs that cannot be crossed with a standard guidewire.
What is the current status of trial NCT03403426?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2018-02-13. Estimated completion is 2019-08-08.
What interventions are being tested in trial NCT03403426?
The interventions under investigation include: Wingman Crossing Catheter (DEVICE).
Who is sponsoring clinical trial NCT03403426?
This trial is sponsored by ReFlow Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03403426's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI